Fresenius Kabi Oncology Ltd Share Price
Equities
INE575G01010
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- INR | - |
2016 | AstraZeneca sells rights to anaesthetics for up to $770 million | RE |
2015 | Fresenius SE KGaA : Kabi sells German oncology compounding business | RE |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 30/06/18 | |
Rahul Sharma
DFI | Director of Finance/CFO | - | - |
Maria Gobbi
CHM | Chairman | - | 12/11/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 10/08/08 | |
Director/Board Member | - | 20/07/07 | |
Maria Gobbi
CHM | Chairman | - | 12/11/14 |
1st Jan change | Capi. | |
---|---|---|
+8.29% | 114B | |
+10.21% | 104B | |
+0.44% | 22.28B | |
-11.90% | 22.41B | |
-4.59% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- Stock